Evidence map›Paper›PMID 25941434›Full record

ReviewJournal of clinical and experimental hepatology2015

Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix.

Denver M Faulk, Justin D Wildemann, Stephen F Badylak

Abstract readReview
In one paragraph

Review in Journal of clinical and experimental hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. ECM roles and biomechanics in cardiac tissue decellularization.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Denver M FaulkDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA ; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Justin D WildemannDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Stephen F BadylakDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA ; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA ; Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The definitive treatment for patients with end-stage liver disease is orthotropic transplantation. However, this option is limited by the disparity between the number of patients needing transplantation and the number of available livers. This issue is becoming more severe as the population ages and as the number of new cases of end-stage liver failure increases. Patients fortunate enough to receive a transplant are required to receive immunosuppressive therapy and must live with the associated morbidity. Whole organ engineering of the liver may offer a solution to this liver donor shortfall. It has been shown that perfusion decellularization of a whole allogeneic or xenogeneic liver generates a three-dimensional ECM scaffold with intact macro and micro architecture of the native liver. A decellularized liver provides an ideal transplantable scaffold with all the necessary ultrastructure and signaling cues for cell attachment, differentiation, vascularization, and function. In this review, an overview of complementary strategies for creating functional liver grafts suitable for transplantation is provided. Early milestones have been met by combining stem and progenitor cells with increasingly complex scaffold materials and culture conditions.

Indexed as

BAL, biohybrid artificial liverbiologic scaffoldBMC, basement membrane complexCHAPS, 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonateDAMP, damage associated molecular patterndecellularizationECM, extracellular matrixextracellular matrixHMECs, human microvascular endothelial cellsliver tissue engineeringNPCs, non-parenchymal cellsorgan engineeringPLECM, porcine-liver-derived extracellular matrixSDS, sodium dodecyl sulfateSEC, sinusoidal endothelial cellSEM, scanning electron microscopy

Identifiers

PMID25941434
PMCPMC4415199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.